Cancer screening coverage: cervical cancer (aged 25 to 49 years old) - WMCA

The proportion of women in the resident population eligible for cervical screening aged 25 to 49 years at end of period reported who were screened adequately within the previous 3.5 years.RationaleCervical screening supports detection of cell abnormalities that may become cancer and is estimated to save 4,500 lives in England each year. Inclusion of this indicator provides an opportunity to incentivise screening promotion and other local initiatives to increase coverage of cervical cancer screening.Improvements in coverage would mean more cervical cancer is prevented or detected at earlier, more treatable stages.Definition of numeratorTested women (numerator) is the number of eligible women with a technically adequate screen within the previous 3.5 years.Definition of denominatorEligible women (denominator) is the number of women aged 25 to 49 years resident in the area (determined by postcode of residence) who are eligible for cervical screening at a given point in time, excluding those without a cervix.CaveatsData for ICBs are estimated from local authority data. In most cases ICBs are coterminous with local authorities, so the ICB figures are precise. In cases where local authorities cross ICB boundaries, the local authority data are proportionally split between ICBs, based on population located in each ICB.The affected ICBs are:Bath and North East Somerset, Swindon and Wiltshire;Bedfordshire, Luton and Milton Keynes;Buckinghamshire, Oxfordshire and Berkshire West;Cambridgeshire and Peterborough;Frimley;Hampshire and Isle of Wight;Hertfordshire and West Essex;Humber and North Yorkshire;Lancashire and South Cumbria;Norfolk and Waveney;North East and North Cumbria;Suffolk and North East Essex;Surrey Heartlands;Sussex;West Yorkshire.Please be aware that the April 2019 to March 2020, April 2020 to March 2021 and April 2021 to March 2022 data covers the time period affected by the COVID19 pandemic and therefore data for this period should be interpreted with caution.This indicator gives screening coverage by local authority of residence. This is not the same as the indicator based on population registered with primary care organisations which include patients wherever they live. This is likely to result in different England totals depending on selected (registered or resident) population footprint.The indicator excludes women outside the target age range for the screening programme who may self refer for screening.

在报告期末，居住人口中符合年龄25至49岁且适于宫颈癌筛查的妇女中，在过去3.5年内接受充分筛查的比例。
理据：宫颈癌筛查有助于发现可能演变成癌症的细胞异常，据估计，每年可为英格兰挽救4,500人的生命。纳入此指标为激励筛查推广及提高宫颈癌筛查覆盖率的本地倡议提供了机会。覆盖率的提升意味着更多宫颈癌可以得到预防或更早、更易治疗的阶段被发现。
分子定义：接受筛查的妇女（分子）是指在过去3.5年内进行技术性充分筛查的符合条件的妇女数量。
分母定义：符合条件的妇女（分母）是指居住在该地区（由居住地邮编确定）且在特定时间点符合宫颈癌筛查条件的25至49岁妇女的数量，不包括无宫颈的妇女。
注意事项：ICB的数据是从地方政府数据估计得出的。在大多数情况下，ICB与地方政府界限一致，因此ICB数据精确。在地方政府跨越ICB边界的情况下，地方政府数据将根据每个ICB的人口比例分配到ICB中。受影响的ICB包括：巴思和东北索美塞、斯旺西和威尔特郡；贝德福德郡、卢顿和米尔顿凯恩斯；白金汉郡、牛津郡和伯克郡西部；剑桥郡和彼得伯勒；弗里姆利；汉普郡和怀特岛；赫特福德郡和西艾塞克斯；亨伯和北约克郡；兰开夏郡和南坎布里亚；诺福克和韦恩；东北和南坎布里亚；萨福克和东北艾塞克斯；萨里心脏地带；苏塞克斯；西约克郡。请注意，2019年4月至2020年3月、2020年4月至2021年3月和2021年4月至2022年3月的数据覆盖了受COVID-19大流行影响的时期，因此应谨慎解读这段时间的数据。此指标提供了居住地地方政府的筛查覆盖率。这与基于在初级保健机构注册的患者的指标不同，这些患者无论居住何地都会被包括在内。这可能导致根据所选（注册或居住）人口足迹的英格兰总数据不同。此指标排除了可能自行申请筛查但不在筛查项目目标年龄范围内的妇女。